Complement SC5b-9 (TCC / MAC) Mouse Monoclonal Antibody [Clone ID: 3R2/0]
Specifications
| Product Data | |
| Clone Name | 3R2/0 |
|---|---|
| Application | ELISA, FC, IHC, WB |
| Recommended Dilution | ELISA. Western Blot. Flow Cytometry. Immunohistochemistry on Frozen Sections. Recommended Positive Control: Kidney from post streptoccal glomerulonephritis patients. |
| Reactivity | Human |
| Antibody Host | Mouse |
| Isotype | IgG2b |
| Clonality | Monoclonal |
| Specificity | This antibody recognises the SC5b-9 complex of around 330 kDa. |
| Buffer | Borate buffered saline, pH8.4 containing 0.09% Sodium Azide as preservative State: Purified State: Liquid purified IgG fraction |
| Concentration | lot specific |
| Purification | Affinity Chromatography on Protein A |
| Conjugation | Unconjugated |
| Storage | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. |
| Stability | Shelf life: one year from despatch. |
| Shipping | Blue Ice |
| Background | Both the classical and alternative complement pathways result in the formation of the cytolysis inducing C5b-9 complex. This complex is composed of 190 kDa C5b which is bound to cells via 71 kDa C9. Sublytic assembly of C5b-9 on plasma membranes induces cell cycle activation and survival. The binding of C5b-9 to the 75 kDa S-protein (or vitronectin) in the fluid phase prevents C5b-9 from assembling on the plasma membrane, deactivating it and forming the SC5b-9 complex. SC5b-9 is stable in vitro and is therefore a reliable indicator of terminal complement pathway activation. |
| Synonyms | Terminal complement complex, Membrane attack complex |
| Note | Removal of Sodium Azide is recommended prior to use in functional assays. |
| Reference Data | |
Reviews
Documents
| Product Manuals |
| FAQs |
| SDS |